Nykredit A S Makes New $20.64 Million Investment in Edwards Lifesciences Corporation $EW
MarketBeat
Nykredit A S acquired a new stake in Edwards Lifesciences Corporation (NYSE:EW - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 228,193 shares of the medical research company's stock, valued at approximately $20,642,000. Other ins
NYSE:EW